AI Engines For more Details: Perplexity Kagi Labs You
Vasodilation: Papaverine hydrochloride is a vasodilator, meaning it relaxes the smooth muscles in blood vessels, leading to the dilation of blood vessels. This property can help improve blood flow to various parts of the body.
Angina Pectoris: Papaverine hydrochloride may be used to relieve symptoms of angina pectoris, a condition characterized by chest pain or discomfort due to reduced blood flow to the heart muscle. By dilating coronary arteries, papaverine hydrochloride can increase blood flow to the heart and alleviate symptoms of angina.
Peripheral Vascular Disease: Papaverine hydrochloride is also used to treat peripheral vascular disease (PVD), a condition in which blood flow to the limbs is restricted due to narrowed or blocked blood vessels. By dilating peripheral arteries, papaverine hydrochloride can improve blood circulation to the limbs and alleviate symptoms such as leg pain and cramping.
Erectile Dysfunction: Papaverine hydrochloride may be used as part of intracavernosal injection therapy for the treatment of erectile dysfunction (ED). When injected directly into the penis, papaverine hydrochloride relaxes the smooth muscles in the penile arteries, leading to increased blood flow and penile erection.
Smooth Muscle Spasm: Papaverine hydrochloride can also be used to relieve smooth muscle spasm in various organs and tissues, such as the gastrointestinal tract and urinary tract. It works by inhibiting the contraction of smooth muscle cells, leading to muscle relaxation and symptom relief.
Side Effects: Common side effects of papaverine hydrochloride may include headache, dizziness, flushing, low blood pressure (hypotension), nausea, vomiting, and transient changes in heart rate. These side effects are usually mild and transient.
Allergic Reactions: Some individuals may experience allergic reactions to papaverine hydrochloride, which can manifest as skin rash, itching, swelling, or difficulty breathing. Allergic reactions require immediate medical attention.
Priapism: Priapism, a prolonged and painful erection unrelated to sexual arousal, is a rare but serious side effect associated with the use of papaverine hydrochloride for the treatment of erectile dysfunction. Priapism requires immediate medical attention to prevent complications such as tissue damage and erectile dysfunction.
Drug Interactions: Papaverine hydrochloride may interact with other medications, particularly other vasodilators, blood pressure-lowering drugs, and medications that affect heart rate. It's essential to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.
Pregnancy and Breastfeeding: The safety of papaverine hydrochloride during pregnancy and breastfeeding has not been well-established. It is generally not recommended for use in pregnant or breastfeeding women unless the potential benefits outweigh the risks.
Liver and Kidney Function: Papaverine hydrochloride should be used with caution in individuals with impaired liver or kidney function, as dosage adjustments may be necessary based on the severity of impairment.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Flavonifractor plautii | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Hungatella hathewayi | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Alistipes senegalensis | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Alistipes onderdonkii | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Alistipes shahii | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Enterocloster clostridioformis | species | Decreases |
0 | 1 | Alistipes finegoldii | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Parabacteroides merdae | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Alistipes dispar | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | 0.2 | |
Acne | 0.3 | -0.3 | |
ADHD | 2.7 | 1.1 | 1.45 |
Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.1 | 4 |
Allergic Rhinitis (Hay Fever) | 1.2 | 1.8 | -0.5 |
Allergies | 4.5 | 1.5 | 2 |
Allergy to milk products | 1.3 | 0.9 | 0.44 |
Alopecia (Hair Loss) | 0.9 | 0.1 | 8 |
Alzheimer's disease | 3 | 4.9 | -0.63 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.2 | 0.5 | 3.4 |
Ankylosing spondylitis | 2.5 | 0.6 | 3.17 |
Anorexia Nervosa | 0.8 | 1.8 | -1.25 |
Antiphospholipid syndrome (APS) | 1 | 1 | |
Asthma | 3.6 | 1.7 | 1.12 |
Atherosclerosis | 1.2 | 1.7 | -0.42 |
Atrial fibrillation | 2.1 | 0.7 | 2 |
Autism | 6.1 | 5.4 | 0.13 |
Autoimmune Disease | 0.3 | 0.6 | -1 |
Barrett esophagus cancer | 0.1 | 0.1 | |
benign prostatic hyperplasia | 0.1 | 0.2 | -1 |
Biofilm | 0.4 | 0.4 | |
Bipolar Disorder | 1 | 1.2 | -0.2 |
Brain Trauma | 0.6 | 0.9 | -0.5 |
Breast Cancer | 0.2 | 0.2 | |
Cancer (General) | 0.5 | 2 | -3 |
Carcinoma | 2 | 1.5 | 0.33 |
Celiac Disease | 2.1 | 2.5 | -0.19 |
Cerebral Palsy | 0.7 | 0.8 | -0.14 |
Chronic Fatigue Syndrome | 3.8 | 4.2 | -0.11 |
Chronic Kidney Disease | 3.1 | 2.4 | 0.29 |
Chronic Lyme | 0.5 | 0.5 | 0 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.7 | 1.2 | -0.71 |
Chronic Urticaria (Hives) | 0.5 | 0.4 | 0.25 |
Coagulation / Micro clot triggering bacteria | 0.4 | 0.6 | -0.5 |
Cognitive Function | 0.9 | 0.9 | 0 |
Colorectal Cancer | 2.9 | 1.4 | 1.07 |
Constipation | 0.8 | 0.6 | 0.33 |
Coronary artery disease | 0.8 | 2.1 | -1.63 |
COVID-19 | 7.2 | 8.8 | -0.22 |
Crohn's Disease | 3.7 | 4 | -0.08 |
Cushing's Syndrome (hypercortisolism) | 0.3 | -0.3 | |
cystic fibrosis | 0.3 | 1.4 | -3.67 |
d-lactic acidosis (one form of brain fog) | 0.3 | 0.3 | |
deep vein thrombosis | 1 | 0.5 | 1 |
Denture Wearers Oral Shifts | 0.3 | 0.3 | |
Depression | 7.3 | 6.3 | 0.16 |
Dermatomyositis | 0.3 | -0.3 | |
Eczema | 0.4 | 0.8 | -1 |
Endometriosis | 1.7 | 1.7 | 0 |
Eosinophilic Esophagitis | 0.1 | -0.1 | |
Epilepsy | 1.9 | 1.3 | 0.46 |
erectile dysfunction | 0.3 | 0.3 | 0 |
Fibromyalgia | 2.4 | 1.2 | 1 |
Functional constipation / chronic idiopathic constipation | 4 | 3.3 | 0.21 |
gallstone disease (gsd) | 1.1 | 0.7 | 0.57 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.4 | 1.5 | -2.75 |
Generalized anxiety disorder | 1.6 | 1.6 | 0 |
giant cell arteritis | 0 | 0 | |
Gout | 1.4 | 0.5 | 1.8 |
Graves' disease | 1 | 1.7 | -0.7 |
Gulf War Syndrome | 0.7 | 0.9 | -0.29 |
Halitosis | 0.3 | 0.3 | |
Hashimoto's thyroiditis | 2.2 | 1.6 | 0.38 |
Heart Failure | 2.2 | 1.3 | 0.69 |
hemorrhagic stroke | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.6 | 0.1 | 5 |
High Histamine/low DAO | 0.6 | 0.3 | 1 |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.2 | 1.5 |
hyperglycemia | 0.6 | 1.3 | -1.17 |
Hyperlipidemia (High Blood Fats) | 0.6 | 0.2 | 2 |
hypersomnia | 0.5 | -0.5 | |
hypertension (High Blood Pressure | 2.7 | 4.5 | -0.67 |
Hypothyroidism | 0.1 | 1.3 | -12 |
Hypoxia | 0.9 | 0.9 | |
IgA nephropathy (IgAN) | 0.8 | 2.8 | -2.5 |
Inflammatory Bowel Disease | 4.9 | 6.7 | -0.37 |
Insomnia | 1.2 | 1.7 | -0.42 |
Intelligence | 0.9 | 0.1 | 8 |
Intracranial aneurysms | 0.7 | 0.7 | 0 |
Irritable Bowel Syndrome | 4.2 | 3.2 | 0.31 |
ischemic stroke | 1.9 | 0.7 | 1.71 |
Liver Cirrhosis | 3.8 | 2 | 0.9 |
Long COVID | 5.7 | 6.1 | -0.07 |
Low bone mineral density | 1.3 | -1.3 | |
Lung Cancer | 0.7 | 1 | -0.43 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.1 | 0.7 | -6 |
ME/CFS with IBS | 0.8 | 2.4 | -2 |
ME/CFS without IBS | 1.2 | 1 | 0.2 |
Menopause | 1.9 | 0.5 | 2.8 |
Metabolic Syndrome | 4.5 | 4.7 | -0.04 |
Mood Disorders | 7.7 | 5.3 | 0.45 |
multiple chemical sensitivity [MCS] | 0.3 | 0.4 | -0.33 |
Multiple Sclerosis | 3.7 | 3.3 | 0.12 |
Multiple system atrophy (MSA) | 0.9 | 0.6 | 0.5 |
myasthenia gravis | 0.1 | 0.3 | -2 |
neuropathic pain | 0.4 | 2.5 | -5.25 |
Neuropathy (all types) | 0.8 | 1.2 | -0.5 |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.3 | 4.4 | -0.33 |
NonCeliac Gluten Sensitivity | 1.6 | 0.4 | 3 |
Obesity | 7.1 | 4.7 | 0.51 |
obsessive-compulsive disorder | 3.5 | 2.3 | 0.52 |
Osteoarthritis | 1.5 | 0.9 | 0.67 |
Osteoporosis | 1.2 | 1 | 0.2 |
pancreatic cancer | 0.3 | 0.3 | |
Parkinson's Disease | 6.1 | 4.1 | 0.49 |
Polycystic ovary syndrome | 3.1 | 1.7 | 0.82 |
Postural orthostatic tachycardia syndrome | 0 | 0.6 | 0 |
Premenstrual dysphoric disorder | 0.8 | 0.1 | 7 |
primary biliary cholangitis | 0.2 | 0.3 | -0.5 |
Primary sclerosing cholangitis | 0.9 | 2.2 | -1.44 |
Psoriasis | 1.7 | 1.5 | 0.13 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.2 | 2.4 | 0.75 |
Rosacea | 1.1 | 0.4 | 1.75 |
Schizophrenia | 4.6 | 2.3 | 1 |
scoliosis | 0.7 | 0.7 | 0 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 1.4 | 1.4 | 0 |
Sleep Apnea | 1.1 | 1.5 | -0.36 |
Slow gastric motility / Gastroparesis | 0.6 | 0.3 | 1 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1 | 0.6 | 0.67 |
Stress / posttraumatic stress disorder | 1.3 | 2.4 | -0.85 |
Systemic Lupus Erythematosus | 2.1 | 1.7 | 0.24 |
Tic Disorder | 0.4 | 0.9 | -1.25 |
Tourette syndrome | 0.1 | 0.2 | -1 |
Type 1 Diabetes | 2.2 | 2.8 | -0.27 |
Type 2 Diabetes | 5.3 | 3.4 | 0.56 |
Ulcerative colitis | 2.5 | 4.4 | -0.76 |
Unhealthy Ageing | 3.1 | 1.6 | 0.94 |
Vitiligo | 1.1 | 1.3 | -0.18 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]